Skip to content
  • Our Company
  • The Gift of Sight
  • Our Innovation
  • Investors + Media
Open Menu
  • Our Company
    • ABOUT US
    • OUR TEAM
      • Management Team
      • Board of Directors
    • OUR CULTURE
  • The Gift of Sight
    • WHY SUPERIOR VISION
      OUTCOMES MATTER
  • Our Innovation
    • PIPELINE
    • SCIENCE
    • CLINICAL TRIALS IN WET AMD
      • Sozinibercept Phase 3 Program
      • Sozinibercept Phase 2B Results
    • CLINICAL TRIALS IN DME
    • PUBLICATIONS
      • Scientific Presentations
      • Expanded Access Policy
  • Investors & Media
    • OVERVIEW
    • STOCK INFORMATION
    • PRESS RELEASES
    • EVENTS AND PRESENTATIONS
    • FILINGS
    • CORPORATE GOVERNANCE
    • INVESTOR RESOURCES
  • NEWS
  • JOIN US
  • CONTACT US

SEARCH RESULTS FOR

Opthea Announces Publication in Diabetic Macular Edema

READ MORE

Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference

READ MORE

Opthea’s Wet AMD Program to be Featured at FLORetina 2024

READ MORE

Opthea to Participate in Citi 2024 Global Healthcare Conference

READ MORE

Opthea Appoints Kathy Connell to Board of Directors

READ MORE

Opthea’s Wet AMD Program Featured at Ophthalmology Events

READ MORE

Opthea to Participate in November Investor Conferences

READ MORE

About Us

READ MORE

Our Team

READ MORE

Our Culture

READ MORE
« Prev
1
2
3
Next »

Stay Informed

Contact Us Publications Investors + Media Subscribe

Locations

Opthea Limited

C/- Prime Company Compliance
Level 9, 505 little Collins Street
Melbourne, Victoria 3000
Australia


Opthea US, Inc.

103 Carnegie Center Blvd
Suite 300
Princeton, New Jersey 08540
United States

Contact Us

Our Company

  • About Us
  • Our Team
  • Our Culture

The Gift of Sight

  • Why Superior Vision
    Outcomes Matter

Our Innovation

  • Pipeline
  • Science
  • Clinical Trials in Wet AMD
  • Clinical Trials in DME
  • Publications

Investors + Media

  • Overview
  • Stock Information
  • Press Releases
  • Events and Presentations
  • Filings
  • Corporate Governance
  • Investor Resources
© 2025 Opthea Limited. All rights reserved.
  • Privacy Policy
  • Terms of use
  • Disclaimer
  • Cookie Notice